HCW Biologics Company
%20.jpg)
HCW Biologics is developing immunotherapies to lengthen healthspan by disrupting the link between cellular senescence and disease.
Funding Status:
Early Stage Venture
Industry:
Others
Estimated Revenue:
$1M to $10M
Technology:
Geroscience
Number Of Exists:
Series B
Headquarters:
United States
Total Funding:
$18.1M
Last Funding Type:
Series B
Investor Type:
Company
Employee Number:
1-10
Investors Number:
2
Founded Date:
2018-04-01